Salil Varshney

1.1k total citations
43 papers, 874 citations indexed

About

Salil Varshney is a scholar working on Physiology, Molecular Biology and Epidemiology. According to data from OpenAlex, Salil Varshney has authored 43 papers receiving a total of 874 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Physiology, 20 papers in Molecular Biology and 20 papers in Epidemiology. Recurrent topics in Salil Varshney's work include Adipose Tissue and Metabolism (21 papers), Adipokines, Inflammation, and Metabolic Diseases (17 papers) and Regulation of Appetite and Obesity (11 papers). Salil Varshney is often cited by papers focused on Adipose Tissue and Metabolism (21 papers), Adipokines, Inflammation, and Metabolic Diseases (17 papers) and Regulation of Appetite and Obesity (11 papers). Salil Varshney collaborates with scholars based in India, United States and Japan. Salil Varshney's co-authors include Anil Nilkanth Gaikwad, Kripa Shankar, Sujith Rajan, Durgesh Kumar, Abhishek Gupta, Muheeb Beg, Ankita Srivastava, Jeffrey M. Zigman, Deepali Gupta and Vishal M. Balaramnavar and has published in prestigious journals such as Journal of Clinical Investigation, Free Radical Biology and Medicine and Endocrinology.

In The Last Decade

Salil Varshney

42 papers receiving 865 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Salil Varshney India 21 345 321 224 146 105 43 874
Kripa Shankar India 21 257 0.7× 380 1.2× 233 1.0× 281 1.9× 121 1.2× 40 900
Chu-Sook Kim South Korea 17 447 1.3× 387 1.2× 309 1.4× 68 0.5× 94 0.9× 28 1.2k
Yvette Fernandez France 15 434 1.3× 355 1.1× 172 0.8× 74 0.5× 53 0.5× 19 1.1k
Taku Uemura Japan 15 541 1.6× 341 1.1× 239 1.1× 59 0.4× 240 2.3× 19 1.1k
Laura Baselga‐Escudero Spain 15 256 0.7× 244 0.8× 154 0.7× 130 0.9× 76 0.7× 21 720
Leida Maria Botion Brazil 17 356 1.0× 403 1.3× 215 1.0× 80 0.5× 258 2.5× 41 1.1k
Yu-Jin Hwang South Korea 16 688 2.0× 537 1.7× 242 1.1× 32 0.2× 150 1.4× 31 1.3k
Hui‐Kang Liu Taiwan 20 514 1.5× 192 0.6× 154 0.7× 28 0.2× 225 2.1× 64 1.2k
Min Ho South Korea 17 537 1.6× 169 0.5× 98 0.4× 38 0.3× 41 0.4× 59 977
Xiao‐Yi Zeng Australia 20 451 1.3× 373 1.2× 398 1.8× 42 0.3× 387 3.7× 26 1.2k

Countries citing papers authored by Salil Varshney

Since Specialization
Citations

This map shows the geographic impact of Salil Varshney's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Salil Varshney with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Salil Varshney more than expected).

Fields of papers citing papers by Salil Varshney

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Salil Varshney. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Salil Varshney. The network helps show where Salil Varshney may publish in the future.

Co-authorship network of co-authors of Salil Varshney

This figure shows the co-authorship network connecting the top 25 collaborators of Salil Varshney. A scholar is included among the top collaborators of Salil Varshney based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Salil Varshney. Salil Varshney is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Varshney, Salil, Durgesh Kumar, Abhishek Gupta, et al.. (2024). Flavopiridol inhibits adipogenesis and improves metabolic homeostasis by ameliorating adipose tissue inflammation in a diet-induced obesity model. Biomedicine & Pharmacotherapy. 179. 117330–117330. 2 indexed citations
3.
Gupta, Deepali, Kripa Shankar, Salil Varshney, et al.. (2024). Impact of Ghrelin on Islet Size in Nonpregnant and Pregnant Female Mice. Endocrinology. 165(6). 1 indexed citations
4.
Varshney, Salil, Kripa Shankar, Lindsey Anderson, et al.. (2024). The LEAP2 Response to Cancer-Related Anorexia-Cachexia Syndrome in Male Mice and Patients. Endocrinology. 165(11). 5 indexed citations
5.
Singh, Omprakash, Salil Varshney, Kripa Shankar, et al.. (2023). Ghrelin-responsive mediobasal hypothalamic neurons mediate exercise-associated food intake and exercise endurance. JCI Insight. 8(24). 2 indexed citations
6.
7.
Shankar, Kripa, Deepali Gupta, Salil Varshney, et al.. (2021). Ghrelin cell–expressed insulin receptors mediate meal- and obesity-induced declines in plasma ghrelin. JCI Insight. 6(18). 12 indexed citations
8.
Mishra, Tripti, Salil Varshney, Kapil Dev, et al.. (2021). Coelogin ameliorates metabolic dyshomeostasis by regulating adipogenesis and enhancing energy expenditure in adipose tissue. Pharmacological Research. 172. 105776–105776. 11 indexed citations
9.
Shankar, Kripa, Nathan P. Metzger, Omprakash Singh, et al.. (2021). LEAP2 deletion in mice enhances ghrelin's actions as an orexigen and growth hormone secretagogue. Molecular Metabolism. 53. 101327–101327. 60 indexed citations
10.
Gupta, Deepali, et al.. (2020). “A LEAP 2 conclusions? Targeting the ghrelin system to treat obesity and diabetes”. Molecular Metabolism. 46. 101128–101128. 35 indexed citations
11.
Singh, Pratibha, Vikas Bajpai, Salil Varshney, et al.. (2020). Determination of bioactive compounds of Artemisia Spp. plant extracts by LC–MS/MS technique and their in-vitro anti-adipogenic activity screening. Journal of Pharmaceutical and Biomedical Analysis. 193. 113707–113707. 27 indexed citations
12.
Kumar, Durgesh, Kripa Shankar, Salil Varshney, et al.. (2018). Saroglitazar reduces obesity and associated inflammatory consequences in murine adipose tissue. European Journal of Pharmacology. 822. 32–42. 24 indexed citations
13.
Shankar, Kripa, Muheeb Beg, Sujith Rajan, et al.. (2018). Chronic hyperinsulinemia induced miR-27b is linked to adipocyte insulin resistance by targeting insulin receptor. Journal of Molecular Medicine. 96(3-4). 315–331. 29 indexed citations
14.
Gupta, Amit K., Ravi Sonkar, Salil Varshney, et al.. (2018). Lipid Lowering Oxopropanylindole Hydrazone Derivatives with Antioxidant and Anti-hyperglycemic Activity. Current Topics in Medicinal Chemistry. 18(26). 2256–2265. 2 indexed citations
15.
Rajan, Sujith, Surendra K. Puri, Durgesh Kumar, et al.. (2017). Novel indole and triazole based hybrid molecules exhibit potent anti-adipogenic and antidyslipidemic activity by activating Wnt3a/β-catenin pathway. European Journal of Medicinal Chemistry. 143. 1345–1360. 54 indexed citations
16.
Gupta, Abhishek, Ashok Kumar, Durgesh Kumar, et al.. (2017). Ethyl acetate fraction of Eclipta alba: a potential phytopharmaceutical targeting adipocyte differentiation. Biomedicine & Pharmacotherapy. 96. 572–583. 14 indexed citations
17.
Beg, Muheeb, Ankita Srivastava, Kripa Shankar, et al.. (2016). PPP2R5B, a regulatory subunit of PP2A, contributes to adipocyte insulin resistance. Molecular and Cellular Endocrinology. 437. 97–107. 20 indexed citations
18.
Beg, Muheeb, Kripa Shankar, Salil Varshney, et al.. (2014). A clerodane diterpene inhibit adipogenesis by cell cycle arrest and ameliorate obesity in C57BL/6 mice. Molecular and Cellular Endocrinology. 399. 373–385. 28 indexed citations
19.
Varshney, Salil, Kripa Shankar, Muheeb Beg, et al.. (2014). Rohitukine inhibits in vitro adipogenesis arresting mitotic clonal expansion and improves dyslipidemia in vivo. Journal of Lipid Research. 55(6). 1019–1032. 55 indexed citations
20.
Beg, Muheeb, Parul Chauhan, Salil Varshney, et al.. (2013). A withanolide coagulin-L inhibits adipogenesis modulating Wnt/β-catenin pathway and cell cycle in mitotic clonal expansion. Phytomedicine. 21(4). 406–414. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kripa Shankar Breakdown of academic impact, for papers by Chu-Sook Kim Breakdown of academic impact, for papers by Yvette Fernandez Breakdown of academic impact, for papers by Taku Uemura Breakdown of academic impact, for papers by Laura Baselga‐Escudero Breakdown of academic impact, for papers by Leida Maria Botion Breakdown of academic impact, for papers by Yu-Jin Hwang Breakdown of academic impact, for papers by Hui‐Kang Liu Breakdown of academic impact, for papers by Min Ho Breakdown of academic impact, for papers by Xiao‐Yi Zeng
Rankless by CCL
2026